Evidence shows cigarette sales increase after vape bans

SState-level vaping bans are associated with increased cigarette sales, news reports to research. The study, published in the scientific journal Health valueadds to a growing body of evidence that banning the sale of e-cigarettes has potentially driven more and more people away from safer alternatives to nicotine and back to smoking.

They found that an additional 3.4 million packs of cigarettes were sold at convenience stores in the three states over a three-month study period.

Using state-level cigarette sales data, the researchers found that Massachusetts, which enacted a total ban on nicotine vaping, had 7.5% more than expected. per inhabitant cigarette sales. Rhode Island and Washington, which have enacted bans on nicotine vapes without tobacco flavor, had an average estimate 4.6% higher than expected per inhabitant also the sale of cigarettes. Based on actual and estimated cigarette sales, the researchers suggested that an additional 3.4 million packs of cigarettes were sold at convenience stores in the three states during a three-month study period starting in the effective date of each respective prohibition.

The study was funded by Juul Labs and has so far had little impact, perhaps due to the fact that many tobacco control actors now dismiss any industry-backed research as actually biased. This debate, which likely has its origins in Big Tobacco’s decades-long suppression of data, has been reinvigorated in recent times: the Society for Research on Nicotine and Tobacco (SRNT), for example, has explicitly banned industry to present at its conferences…a move that has led to resignations and condemnation that tobacco control is now ‘anti-science’.

The researchers looked at data from the fall of 2019, when lawmakers worried about “EVALI” — a series of then-mysterious lung diseases that politicians were quick to link to vaping. Although the Centers for Disease Control and Prevention (CDC) subscribed most cases to contaminated and illicit THC cartridges in November 2019, state governments jumped on a panic and called for emergency vaping bans that, in some cases, eventually became permanent.

In response to the EVALI outbreak, Massachusetts instituted an emergency ban on all nicotine vapes beginning September 24, 2019. Rhode Island and Washington followed suit and instituted emergency bans of four months on nicotine vapes without tobacco flavor on October 4, 2019, and October 10, 2019, respectively. (Massachusetts has since been permanently banned the sale of flavored vaping products, including menthol, and emergency bans in Rhode Island and Washington have each expired, although permanent flavor bans still seem to remain on the table.)

Previous studies have found results similar to Health value paper.

Nicotine vaping hasn’t been medically associated with any “EVALI” diagnosis, but misinformation has swirled: Spurred on by policymakers and sensationalized media reports, concerns about youth vaping rates are rising. are directly transformed into fears about lethal vaping products. The misleading message was simple: teens were using vapes and, in some cases, dying. More than two years later, the CDC still hasn’t issued a formal correction that nicotine vaping had nothing to do with lung damage.

Previous studies have found results similar to Health value paper: One in the harm reduction journal by co-authors at Boston University suggested that the misconceptions about EVALI, which led to the Massachusetts ban, appear to have increased cigarette smoking throughout Boston. Another, by Dr. Abigail Friedman of Yale in JAMA Pediatricsfound that after San Francisco banned flavored vapes and tobacco products, teens in high schools across the city were more likely to start smoking than teenagers in comparable US school districts.


Photograph by Tomasz G. Sienicki via Wikimedia Commons/Creative Commons 2.0

The Influence Foundation, which operates Filteredreceived grants from Juul Labs. Filtereds Editorial independence policy applies.

About Margaret Shaw

Check Also

Top FDA tobacco official resigns to take job at Philip Morris International

OOn July 26, Matthew Holman, director of the Food and Drug Administration’s Center for Tobacco …